The following articles (labelled with PubMed ID or TBD) are for your review
PMID | Data | Article Title | Organization |
28259626 |
90 |
Perfluorinated hydroxamic acids are potent and selective inhibitors of HDAC-like enzymes from Pseudomonas aeruginosa. |
University of Applied Sciences Darmstadt |
15149697 |
10 |
Thiol-based SAHA analogues as potent histone deacetylase inhibitors. |
Nagoya City University |
15109664 |
4 |
Three new cyclostellettamines, which inhibit histone deacetylase, from a marine sponge of the genus Xestospongia. |
The University of Tokyo |
15109636 |
14 |
Stereodefined and polyunsaturated inhibitors of histone deacetylase based on (2E,4E)-5-arylpenta-2,4-dienoic acid hydroxyamides. |
University College London |
14643318 |
23 |
Novel histone deacetylase inhibitors: design, synthesis, enzyme inhibition, and binding mode study of SAHA-based non-hydroxamates. |
Nagoya City University |
14592473 |
35 |
Heterocyclic ketones as inhibitors of histone deacetylase. |
Abbott Laboratories |
12270175 |
13 |
Succinimide hydroxamic acids as potent inhibitors of histone deacetylase (HDAC). |
Abbott Laboratories |
27377864 |
55 |
Kinetic and structural insights into the binding of histone deacetylase 1 and 2 (HDAC1, 2) inhibitors. |
Broad Institute of Mit and Harvard |
27186676 |
186 |
Development of Purine-Based Hydroxamic Acid Derivatives: Potent Histone Deacetylase Inhibitors with Marked in Vitro and in Vivo Antitumor Activities. |
West China Hospital of Sichuan University |
27142751 |
22 |
Targeting epigenetic reader and eraser: Rational design, synthesis and in vitro evaluation of dimethylisoxazoles derivatives as BRD4/HDAC dual inhibitors. |
China Pharmaceutical University |
26996372 |
10 |
Identification of new quinic acid derivatives as histone deacetylase inhibitors by fluorescence-based cellular assay. |
Sungkyunkwan University |
26890116 |
30 |
Biphenyl-4-yl-acrylohydroxamic acids: Identification of a novel indolyl-substituted HDAC inhibitor with antitumor activity. |
University of Milan |
26819662 |
13 |
Potent, Selective, and CNS-Penetrant Tetrasubstituted Cyclopropane Class IIa Histone Deacetylase (HDAC) Inhibitors. |
Biofocus |
27060764 |
30 |
Computer-aided identification of new histone deacetylase 6 selective inhibitor with anti-sepsis activity. |
Sungkyunkwan University |
26443078 |
108 |
Discovery of Selective Histone Deacetylase 6 Inhibitors Using the Quinazoline as the Cap for the Treatment of Cancer. |
Sichuan University |
26890114 |
56 |
Design, synthesis and biological evaluation of bisthiazole-based trifluoromethyl ketone derivatives as potent HDAC inhibitors with improved cellular efficacy. |
Shanghai Institute of Materia Medica |
26814680 |
71 |
Identification of N-(6-mercaptohexyl)-3-(4-pyridyl)-1H-pyrazole-5-carboxamide and its disulfide prodrug as potent histone deacetylase inhibitors with in vitro and in vivo anti-tumor efficacy. |
Shenyang Pharmaceutical University |
26706171 |
138 |
Novel thiol-based histone deacetylase inhibitors bearing 3-phenyl-1H-pyrazole-5-carboxamide scaffold as surface recognition motif: Design, synthesis and SAR study. |
Shenyang Pharmaceutical University |
26689485 |
18 |
Orally available stilbene derivatives as potent HDAC inhibitors with antiproliferative activities and antitumor effects in human tumor xenografts. |
Orchid Chemicals & Pharmaceuticals |
26741358 |
56 |
Design, synthesis and biological evaluation of N-phenylquinazolin-4-amine hybrids as dual inhibitors of VEGFR-2 and HDAC. |
China Pharmaceutical University |
26629860 |
58 |
Synthesis, biological characterization and molecular modeling insights of spirochromanes as potent HDAC inhibitors. |
European Institute of Oncology |
26753813 |
22 |
Design and synthesis of an activity-based protein profiling probe derived from cinnamic hydroxamic acid. |
University of Minnesota |
26639764 |
17 |
Synthesis and biological activity of diisothiocyanate-derived mercapturic acids. |
Wroclaw University of Technology |
26475519 |
40 |
Hybrids from 4-anilinoquinazoline and hydroxamic acid as dual inhibitors of vascular endothelial growth factor receptor-2 and histone deacetylase. |
China Pharmaceutical University |
26241876 |
1 |
Triazine as a promising scaffold for its versatile biological behavior. |
Thapar University |
26331334 |
99 |
Discovery of Novel Class I Histone Deacetylase Inhibitors with Promising in Vitro and in Vivo Antitumor Activities. |
Guangzhou Institute of Biomedicine and Health |
26086931 |
38 |
Strategies for the Discovery of Target-Specific or Isoform-Selective Modulators. |
Shandong University |
26264503 |
46 |
Discovery of 1-hydroxypyridine-2-thiones as selective histone deacetylase inhibitors and their potential application for treating leukemia. |
University of Minnesota |
26287310 |
87 |
Potent and Selective Inhibitors of Histone Deacetylase-3 Containing Chiral Oxazoline Capping Groups and a N-(2-Aminophenyl)-benzamide Binding Unit. |
University College London |
25637120 |
94 |
Evaluation of histone deacetylase inhibitors (HDACi) as therapeutic leads for human African trypanosomiasis (HAT). |
St. Jude Children'S Research Hospital |
22344701 |
30 |
Biocatalytic synthesis and structure elucidation of cyclized metabolites of the deacetylase inhibitor panobinostat (LBH589). |
Novartis Institutes For Biomedical Research |
25147612 |
25 |
Modulation of Activity Profiles for Largazole-Based HDAC Inhibitors through Alteration of Prodrug Properties. |
University of Florida |
26035239 |
1 |
Natural Product Primary Sulfonamides and Primary Sulfamates. |
Griffith University |
25906087 |
14 |
Design, synthesis, and antitumor evaluation of novel histone deacetylase inhibitors equipped with a phenylsulfonylfuroxan module as a nitric oxide donor. |
Shandong University |
25905694 |
24 |
Novel histone deacetylase inhibitors induce growth arrest, apoptosis, and differentiation in sarcoma cancer stem cells. |
Istituto Ortopedico Rizzoli (Ior) |
25811792 |
32 |
Discovery of Orally Available Runt-Related Transcription Factor 3 (RUNX3) Modulators for Anticancer Chemotherapy by Epigenetic Activation and Protein Stabilization. |
Yonsei University |
25800646 |
40 |
Macrocyclic compounds as anti-cancer agents: design and synthesis of multi-acting inhibitors against HDAC, FLT3 and JAK2. |
Central South University |
25113875 |
14 |
Indole-3-ethylsulfamoylphenylacrylamides: potent histone deacetylase inhibitors with anti-inflammatory activity. |
Taipei Medical University |
25022972 |
24 |
Bicyclic tetrapeptides as potent HDAC inhibitors: effect of aliphatic loop position and hydrophobicity on inhibitory activity. |
University of Rajshahi |
24999749 |
1 |
A potent HDAC inhibitor, 1-alaninechlamydocin, from a Tolypocladium sp. induces G2/M cell cycle arrest and apoptosis in MIA PaCa-2 cells. |
University of Oklahoma |
24997578 |
41 |
Design and synthesis of CHAP31, trapoxin B and HC-toxin based bicyclic tetrapeptides disulfide as potent histone deacetylase inhibitors. |
University of Rajshahi |
24972008 |
36 |
1,3,4-Oxadiazole-containing histone deacetylase inhibitors: anticancer activities in cancer cells. |
Sapienza University of Rome |
24864038 |
112 |
Design and synthesis of novel and highly-active pan-histone deacetylase (pan-HDAC) inhibitors. |
Nippon Pharmaceutical Chemicals |
25462271 |
33 |
Development of 3-hydroxycinnamamide-based HDAC inhibitors with potent in vitro and in vivo anti-tumor activity. |
Shandong University |
25455492 |
22 |
Aurones as histone deacetylase inhibitors: identification of key features. |
University of Geneva |
25454270 |
82 |
Histone deacetylase inhibitors derived from 1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazine and related heterocycles selective for the HDAC6 isoform. |
TBA |
25238284 |
52 |
Identification of a novel aminotetralin class of HDAC6 and HDAC8 selective inhibitors. |
Roche Pharmaceutical Research and Early Development |
25233084 |
247 |
ST7612AA1, a thioacetate-¿(¿-lactam carboxamide) derivative selected from a novel generation of oral HDAC inhibitors. |
R&D Sigma-Tau Industrie Farmaceutiche Riunite |
25221651 |
12 |
Novel antiproliferative chimeric compounds with marked histone deacetylase inhibitory activity. |
University of Bologna |
25218912 |
103 |
Design, synthesis, and biological evaluation of 1, 3-disubstituted-pyrazole derivatives as new class I and IIb histone deacetylase inhibitors. |
Chinese Academy of Sciences |
25176189 |
7 |
Design, synthesis and biological evaluation ofß-boswellic acid based HDAC inhibitors as inducers of cancer cell death. |
Csir-Indian Institute of Integrative Medicine |
24900838 |
30 |
Delayed and Prolonged Histone Hyperacetylation with a Selective HDAC1/HDAC2 Inhibitor. |
Merck Research Laboratories |
24588105 |
56 |
Synthesis and evaluation of new Hsp90 inhibitors based on a 1,4,5-trisubstituted 1,2,3-triazole scaffold. |
Universit£ |
24565573 |
35 |
4,5,6,7-Tetrahydro-isoxazolo-[4,5-c]-pyridines as a new class of cytotoxic Hsp90 inhibitors. |
Universit£ |
24742384 |
90 |
Influence of the adamantyl moiety on the activity of biphenylacrylohydroxamic acid-based HDAC inhibitors. |
Universit£ |
24694055 |
35 |
Discovery of the first N-hydroxycinnamamide-based histone deacetylase 1/3 dual inhibitors with potent oral antitumor activity. |
Shandong University |
17196388 |
12 |
Discovery of uracil-based histone deacetylase inhibitors able to reduce acquired antifungal resistance and trailing growth in Candida albicans. |
Sapienza University of Rome |
24015327 |
42 |
Development of a chimeric c-Src kinase and HDAC inhibitor. |
University of Michigan |
23368884 |
80 |
Potent and selective inhibition of histone deacetylase 6 (HDAC6) does not require a surface-binding motif. |
Broad Institute of Mit and Harvard |
23252603 |
35 |
Histone deacetylase (HDAC) inhibitors with a novel connecting unit linker region reveal a selectivity profile for HDAC4 and HDAC5 with improved activity against chemoresistant cancer cells. |
Heinrich Heine Universit£T |
23116147 |
30 |
Rapid discovery of highly potent and selective inhibitors of histone deacetylase 8 using click chemistry to generate candidate libraries. |
Kyoto Prefectural University of Medicine |
23061376 |
63 |
Pharmacokinetic optimization of class-selective histone deacetylase inhibitors and identification of associated candidate predictive biomarkers of hepatocellular carcinoma tumor response. |
Roche R & D Center China |
23009203 |
39 |
Selective histone deacetylase 6 inhibitors bearing substituted urea linkers inhibit melanoma cell growth. |
University of Illinois At Chicago |
23021104 |
32 |
Cyclic tetrapeptides with thioacetate tails or intramolecular disulfide bridge as potent inhibitors of histone deacetylases. |
Graduate School of Life Science and Systems Engineering |
22642300 |
160 |
Design, synthesis, and biological activity of a novel series of human sirtuin-2-selective inhibitors. |
Kyoto Prefectural University of Medicine |
22541394 |
30 |
Appraisal of GABA and PABA as linker: design and synthesis of novel benzamide based histone deacetylase inhibitors. |
Guru Ghasidas University |
21984958 |
83 |
Potential Agents for Treating Cystic Fibrosis: Cyclic Tetrapeptides that Restore Trafficking and Activity of ¿F508-CFTR. |
TBA |
21874153 |
54 |
Effect of Inhibiting Histone Deacetylase with Short-Chain Carboxylic Acids and Their Hydroxamic Acid Analogs on Vertebrate Development and Neuronal Chromatin. |
Broad Institute of Harvard and Mit |
18809328 |
64 |
Optimization of a series of potent and selective ketone histone deacetylase inhibitors. |
Irbm/Merck Research Laboratories |
17956988 |
14 |
Unraveling the hidden catalytic activity of vertebrate class IIa histone deacetylases. |
Istituto Di Ricerche Di Biologia Molecolare |
18397826 |
18 |
Evaluation of antiangiogenic activity of azumamides by the in vitro vascular organization model using mouse induced pluripotent stem (iPS) cells. |
Waseda University |
18381238 |
4 |
Novel uracil-based 2-aminoanilide and 2-aminoanilide-like derivatives: histone deacetylase inhibition and in-cell activities. |
Sapienza University of Rome |
18182289 |
127 |
Exploration of the internal cavity of histone deacetylase (HDAC) with selective HDAC1/HDAC2 inhibitors (SHI-1:2). |
Merck Research Laboratories |
18247554 |
134 |
Histone deacetylase inhibitors: from bench to clinic. |
Menarini Ricerche |
16987657 |
45 |
A series of novel, potent, and selective histone deacetylase inhibitors. |
Irbm/Merck Research Laboratories |
15454224 |
15 |
Novel histone deacetylase inhibitors: cyclic tetrapeptide with trifluoromethyl and pentafluoroethyl ketones. |
Crest Research Project |
14613312 |
106 |
Histone deacetylase inhibitors. |
Aton Pharma |
14584932 |
23 |
Discovery of (aryloxopropenyl)pyrrolyl hydroxyamides as selective inhibitors of class IIa histone deacetylase homologue HD1-A. |
Sapienza University of Rome |
11206439 |
51 |
Broad spectrum antiprotozoal agents that inhibit histone deacetylase: structure-activity relationships of apicidin. Part 2. |
Merck Research Laboratories |
11206438 |
48 |
Broad spectrum antiprotozoal agents that inhibit histone deacetylase: structure-activity relationships of apicidin. Part 1. |
Merck Research Laboratories |
21417419 |
5 |
Discovery, synthesis, and pharmacological evaluation of spiropiperidine hydroxamic acid based derivatives as structurally novel histone deacetylase (HDAC) inhibitors. |
Dac |
21548582 |
57 |
Design, synthesis, docking, and biological evaluation of novel diazide-containing isoxazole- and pyrazole-based histone deacetylase probes. |
University of Illinois At Chicago |
21875805 |
5 |
Synthesis of a new trifluoromethylketone analogue of l-arginine and contrasting inhibitory activity against human arginase I and histone deacetylase 8. |
Drexel University |
21793558 |
39 |
Thailandepsins: bacterial products with potent histone deacetylase inhibitory activities and broad-spectrum antiproliferative activities. |
University of Wisconsin-Milwaukee |
21634430 |
218 |
Discovery of (2E)-3-{2-butyl-1-[2-(diethylamino)ethyl]-1H-benzimidazol-5-yl}-N-hydroxyacrylamide (SB939), an orally active histone deacetylase inhibitor with a superior preclinical profile. |
S*Bio |
21712146 |
20 |
Synthesis and evaluation of aliphatic-chain hydroxamates capped with osthole derivatives as histone deacetylase inhibitors. |
Taipei Medical University |
21696956 |
243 |
A novel HDAC inhibitor with a hydroxy-pyrimidine scaffold. |
Broad Institute of Harvard and Mit |
21417297 |
220 |
Oxime amides as a novel zinc binding group in histone deacetylase inhibitors: synthesis, biological activity, and computational evaluation. |
Universita` Degli Studi Di Siena |
21256006 |
11 |
Structure and property based design, synthesis and biological evaluation of¿-lactam based HDAC inhibitors. |
Yonsei University |
21073160 |
143 |
Non-Natural Macrocyclic Inhibitors of Histone Deacetylases: Design, Synthesis, and Activity |
TBA |
19966789 |
40 |
Reduced histone deacetylase 7 activity restores function to misfolded CFTR in cystic fibrosis. |
The Scripps Research Institute |
20491440 |
12 |
Synthesis and biological characterization of the histone deacetylase inhibitor largazole and C7- modified analogues. |
Universidade De Vigo |
20451378 |
107 |
Acylurea connected straight chain hydroxamates as novel histone deacetylase inhibitors: Synthesis, SAR, and in vivo antitumor activity. |
S*Bio |
20381359 |
17 |
Synthesis and biological activity of cyclotetrapeptide analogues of the natural HDAC inhibitor FR235222. |
Universit£ |
20205394 |
44 |
Conformational refinement of hydroxamate-based histone deacetylase inhibitors and exploration of 3-piperidin-3-ylindole analogues of dacinostat (LAQ824). |
Novartis Institutes For Biomedical Research |
20045316 |
18 |
Bicyclic peptides as potent inhibitors of histone deacetylases: optimization of alkyl loop length. |
Graduate School of Life Science and Systems Engineering |
20143778 |
70 |
Discovery of 7-(4-(3-ethynylphenylamino)-7-methoxyquinazolin-6-yloxy)-N-hydroxyheptanamide (CUDc-101) as a potent multi-acting HDAC, EGFR, and HER2 inhibitor for the treatment of cancer. |
Curis |
19906529 |
22 |
Identification of a series of substituted 2-piperazinyl-5-pyrimidylhydroxamic acids as potent histone deacetylase inhibitors. |
Ortho-Biotech Oncology Research & Development |
19822426 |
4 |
Novel N-hydroxybenzamide-based HDAC inhibitors with branched CAP group. |
China Pharmaceutical University |
19699639 |
58 |
Diphenylmethylene hydroxamic acids as selective class IIa histone deacetylase inhibitors. |
Methylgene |
19359173 |
51 |
Exploring bis-(indolyl)methane moiety as an alternative and innovative CAP group in the design of histone deacetylase (HDAC) inhibitors. |
Sigma-Tau Research and Development |
19410459 |
33 |
Histone deacetylase inhibitors with a primary amide zinc binding group display antitumor activity in xenograft model. |
Irbm/Merck Research Laboratories |
19285395 |
66 |
N-Hydroxy-(4-oxime)-cinnamide: a versatile scaffold for the synthesis of novel histone deacetylase [correction of deacetilase] (HDAC) inhibitors. |
R&D Sigma-Tau |
19268585 |
30 |
Exploring the pharmacokinetic properties of phosphorus-containing selective HDAC 1 and 2 inhibitors (SHI-1:2). |
Merck Research Laboratories |
19181524 |
46 |
N-Hydroxy-1,2-disubstituted-1H-benzimidazol-5-yl acrylamides as novel histone deacetylase inhibitors: design, synthesis, SAR studies, and in vivo antitumor activity. |
S*Bio |
18951790 |
109 |
SAR profiles of spirocyclic nicotinamide derived selective HDAC1/HDAC2 inhibitors (SHI-1:2). |
Merck Research Laboratories |
18930398 |
117 |
2-Trifluoroacetylthiophene oxadiazoles as potent and selective class II human histone deacetylase inhibitors. |
Irbm-Merck Research Laboratories Rome |
18701301 |
38 |
Design, synthesis and biological evaluation of novel compounds with conjugated structure as anti-tumor agents. |
China Pharmaceutical University |
18672316 |
41 |
Novel amide derivatives as inhibitors of histone deacetylase: design, synthesis and SAR. |
Institute of Organic Synthesis |
18060775 |
67 |
Optimization of biaryl Selective HDAC1&2 Inhibitors (SHI-1:2). |
Merck Research Laboratories |
17900911 |
21 |
Interaction of aliphatic cap group in inhibition of histone deacetylases by cyclic tetrapeptides. |
Graduate School of Life Science and Systems Engineering |
17881232 |
42 |
Molecular design of histone deacetylase inhibitors by aromatic ring shifting in chlamydocin framework. |
Graduate School of Life Science and Systems Engineering |
17588744 |
18 |
Design, synthesis, and evaluation of isoindolinone-hydroxamic acid derivatives as histone deacetylase (HDAC) inhibitors. |
The University of Tokyo |
17447750 |
4 |
Bispyridinium dienes: histone deacetylase inhibitors with selective activities. |
Universidade De Vigo |
16884291 |
12 |
Highly potent and selective histone deacetylase 6 inhibitors designed based on a small-molecular substrate. |
Nagoya City University |
16137884 |
6 |
Design and synthesis of phthalimide-type histone deacetylase inhibitors. |
The University of Tokyo Yayoi |
14698179 |
58 |
Design, synthesis, and activity of HDAC inhibitors with a N-formyl hydroxylamine head group. |
The Scripps Research Institute |
14684344 |
49 |
(2-amino-phenyl)-amides of omega-substituted alkanoic acids as new histone deacetylase inhibitors. |
Methylgene |
32787077 |
23 |
Discovery of Potent Small-Molecule SIRT6 Activators: Structure-Activity Relationship and Anti-Pancreatic Ductal Adenocarcinoma Activity. |
Sichuan University |
32676157 |
102 |
Selective Class I HDAC Inhibitors Based on Aryl Ketone Zinc Binding Induce HIV-1 Protein for Clearance. |
Merck |
32631504 |
29 |
Discovery of 5-(4-methylpiperazin-1-yl)-2-nitroaniline derivatives as a new class of SIRT6 inhibitors. |
Sichuan University |
32273215 |
16 |
Influence of side-chain changes on histone deacetylase inhibitory and cytotoxicity activities of curcuminoid derivatives. |
Khon Kaen University |
32247729 |
23 |
Environment-sensitive fluorescent inhibitors of histone deacetylase. |
Shandong University |
32672458 |
164 |
Characterization of Conformationally Constrained Benzanilide Scaffolds for Potent and Selective HDAC8 Targeting. |
University of Toronto Mississauga |
32435414 |
24 |
Design of First-in-Class Dual EZH2/HDAC Inhibitor: Biochemical Activity and Biological Evaluation in Cancer Cells. |
Sapienza University of Rome |
30660827 |
70 |
Quinolone hybrids and their anti-cancer activities: An overview. |
Qilu University of Technology (Shandong Academy of Sciences) |
32435375 |
22 |
New Dual CK2/HDAC1 Inhibitors with Nanomolar Inhibitory Activity against Both Enzymes. |
Universidad San Pablo-Ceu |
31787463 |
67 |
Novel alkoxyamide-based histone deacetylase inhibitors reverse cisplatin resistance in chemoresistant cancer cells. |
Heinrich-Heine-Universit£T D£Sseldorf |
30594678 |
22 |
Histone deacetylase 8 (HDAC8) and its inhibitors with selectivity to other isoforms: An overview. |
Jadavpur University |
30879863 |
50 |
Design, synthesis and activity evaluation of indole-based double - Branched HDAC1 inhibitors. |
Shandong University |
27774131 |
32 |
Development of a Potent and Selective HDAC8 Inhibitor. |
Boston University |
27614919 |
66 |
Synthesis and biological evaluation of santacruzamate A analogues for anti-proliferative and immunomodulatory activity. |
University of Connecticut |
27460171 |
44 |
Synthesis, biological evaluation and molecular modeling studies of psammaplin A and its analogs as potent histone deacetylases inhibitors and cytotoxic agents. |
Shenyang Pharmaceutical University |
30597327 |
32 |
A novel class of anthraquinone-based HDAC6 inhibitors. |
Keimyung University |
30245394 |
363 |
HDAC as onco target: Reviewing the synthetic approaches with SAR study of their inhibitors. |
Indian Csir-Central Drug Research Institute |
30629434 |
64 |
Discovery of Novel Dual Histone Deacetylase and Mammalian Target of Rapamycin Target Inhibitors as a Promising Strategy for Cancer Therapy. |
TBA |
31630054 |
335 |
Synthesis and structure activity relationship of 1, 3-benzo-thiazine-2-thiones as selective HDAC8 inhibitors. |
University of Applied Sciences |
32212730 |
206 |
Design, Synthesis, and Biological Evaluation of Quinazolin-4-one-Based Hydroxamic Acids as Dual PI3K/HDAC Inhibitors. |
National Center For Advancing Translational Sciences |
30735902 |
69 |
Histone deacetylase 3 inhibitors in learning and memory processes with special emphasis on benzamides. |
Jadavpur University |
31431326 |
63 |
Novel ?,?-unsaturated hydroxamic acid derivatives overcome cisplatin resistance. |
Heinrich-Heine-University D£Sseldorf |
31223439 |
25 |
Extending Cross Metathesis To Identify Selective HDAC Inhibitors: Synthesis, Biological Activities, and Modeling. |
Umr Cnrs 7285 |
31103900 |
36 |
Thioether-based 2-aminobenzamide derivatives: Novel HDAC inhibitors with potent in vitro and in vivo antitumor activity. |
Beijing University of Chemical Technology |
31400938 |
15 |
Anti-tumor activity evaluation of novel tubulin and HDAC dual-targeting inhibitors. |
Qingdao University |
31003060 |
27 |
Design, synthesis and biological evaluation of novel thioquinazolinone-based 2-aminobenzamide derivatives as potent histone deacetylase (HDAC) inhibitors. |
Beijing University of Chemical Technology |
31938464 |
93 |
Class I/IIb-Selective HDAC Inhibitor Exhibits Oral Bioavailability and Therapeutic Efficacy in Acute Myeloid Leukemia. |
University of Toronto Mississauga |
31655430 |
56 |
N-alkyl-hydroxybenzoyl anilide hydroxamates as dual inhibitors of HDAC and HSP90, downregulating IFN-? induced PD-L1 expression. |
Taipei Medical University |
31561937 |
32 |
Recent advances in class IIa histone deacetylases research. |
Heinrich-Heine-Universit£T D£Sseldorf |
31177073 |
22 |
Discovery of 1,2,4-oxadiazole-Containing hydroxamic acid derivatives as histone deacetylase inhibitors potential application in cancer therapy. |
Sichuan University and Collaborative Innovation Center of Biotherapy |
31855601 |
73 |
Synthesis and in Vitro and in Vivo Biological Evaluation of Tissue-Specific Bisthiazole Histone Deacetylase (HDAC) Inhibitors. |
Chinese Academy of Sciences |
31414801 |
84 |
Discovery of a New Isoxazole-3-hydroxamate-Based Histone Deacetylase 6 Inhibitor SS-208 with Antitumor Activity in Syngeneic Melanoma Mouse Models. |
University of Illinois At Chicago |
30901208 |
96 |
Discovery of Novel Janus Kinase (JAK) and Histone Deacetylase (HDAC) Dual Inhibitors for the Treatment of Hematological Malignancies. |
Shandong University |
32347094 |
10 |
Discovery of Novel Fungal Lanosterol 14?-Demethylase (CYP51)/Histone Deacetylase Dual Inhibitors to Treat Azole-Resistant Candidiasis. |
Second Military Medical University |
32321249 |
138 |
Design of Hydrazide-Bearing HDACIs Based on Panobinostat and Their p53 and FLT3-ITD Dependency in Antileukemia Activity. |
Ocean University of China |
32267687 |
37 |
Discovery of Peptide Boronate Derivatives as Histone Deacetylase and Proteasome Dual Inhibitors for Overcoming Bortezomib Resistance of Multiple Myeloma. |
Shandong University |
32153186 |
118 |
Discovery of Thieno[2,3- |
Sichuan University and Collaborative Innovation Center of Biotherapy |
31536895 |
27 |
Indole: A privileged scaffold for the design of anti-cancer agents. |
Hunan University of Science and Technology |
30418766 |
35 |
Kinase and Histone Deacetylase Hybrid Inhibitors for Cancer Therapy. |
Qingdao University |
31762274 |
122 |
Synthesis of Peptoid-Based Class I-Selective Histone Deacetylase Inhibitors with Chemosensitizing Properties. |
Heinrich-Heine-Universit£T D£Sseldorf |
30448419 |
74 |
Highly fluorescent and HDAC6 selective scriptaid analogues. |
Deakin University |
30366254 |
49 |
Identification of novel quinazoline derivatives as potent antiplasmodial agents. |
Universit£ |
31050421 |
48 |
Overview of Recent Strategic Advances in Medicinal Chemistry. |
Shandong University |
31271281 |
9 |
Development of Multifunctional Histone Deacetylase 6 Degraders with Potent Antimyeloma Activity. |
Institute of Biotechnology of The Czech Academy of Sciences |
31117517 |
103 |
Design, Synthesis, and Biological Evaluation of 4-Methyl Quinazoline Derivatives as Anticancer Agents Simultaneously Targeting Phosphoinositide 3-Kinases and Histone Deacetylases. |
TBA |
30463802 |
54 |
Development and characterization of a CNS-penetrant benzhydryl hydroxamic acid class IIa histone deacetylase inhibitor. |
Charles River Discovery (Previously Biofocus) |
31413795 |
57 |
Design, Synthesis, and Biological Evaluation of 2,4-Imidazolinedione Derivatives as HDAC6 Isoform-Selective Inhibitors. |
Shandong University |
26588603 |
21 |
Can Small Chemical Modifications of Natural Pan-inhibitors Modulate the Biological Selectivity? The Case of Curcumin Prenylated Derivatives Acting as HDAC or mPGES-1 Inhibitors. |
Mashhad University of Medical Sciences |
26555243 |
45 |
Novel ?-Carboline/Hydroxamic Acid Hybrids Targeting Both Histone Deacetylase and DNA Display High Anticancer Activity via Regulation of the p53 Signaling Pathway. |
China Pharmaceutical University |
24702857 |
28 |
Search for novel histone deacetylase inhibitors. Part II: design and synthesis of novel isoferulic acid derivatives. |
Xi'An Jiaotong University |
23997923 |
21 |
Discovery and activity profiling of thailandepsins A through F, potent histone deacetylase inhibitors, from |
University of Wisconsin-Milwaukee |
24405391 |
2 |
Mutagenesis studies of the 14 Å internal cavity of histone deacetylase 1: insights toward the acetate-escape hypothesis and selective inhibitor design. |
Wayne State University |
24296013 |
3 |
Synthesis and anticancer activities of thieno[3,2-d]pyrimidines as novel HDAC inhibitors. |
Nantong University |
24164245 |
11 |
Santacruzamate A, a potent and selective histone deacetylase inhibitor from the Panamanian marine cyanobacterium cf. Symploca sp. |
University of Connecticut |
24119555 |
13 |
Design, synthesis and biological evaluation of di-substituted cinnamic hydroxamic acids bearing urea/thiourea unit as potent histone deacetylase inhibitors. |
Central South University |
24095016 |
28 |
Development of novel ferulic acid derivatives as potent histone deacetylase inhibitors. |
Xi'An Jiaotong University |
23820574 |
89 |
Novel N-hydroxyfurylacrylamide-based histone deacetylase (HDAC) inhibitors with branched CAP group (Part 2). |
China Pharmaceutical University |
24900734 |
9 |
Histone Deacetylase 4 (HDAC4) Inhibitors: A Promising Treatment for Huntington's Disease. |
Therachem Research Medilab (India) |
23792316 |
40 |
Design, synthesis and preliminary evaluation of a series of histone deacetylase inhibitors carrying a benzodiazepine ring. |
University of Florence |
24900743 |
86 |
Tropolones as lead-like natural products: the development of potent and selective histone deacetylase inhibitors. |
University of Connecticut |
23768910 |
12 |
Benzofused hydroxamic acids: useful fragments for the preparation of histone deacetylase inhibitors. Part 1: hit identification. |
Menarini Ricerche |
23707260 |
4 |
Discovery of a small molecular compound simultaneously targeting RXR and HADC: design, synthesis, molecular docking and bioassay. |
Shenyang Pharmaceutical University |
23639537 |
9 |
Design, synthesis and biological evaluation of indeno[1,2-d]thiazole derivatives as potent histone deacetylase inhibitors. |
Central South University |
23622981 |
25 |
Dual-acting histone deacetylase-topoisomerase I inhibitors. |
Georgia Institute of Technology |
22877635 |
6 |
Set-up of a new series of HDAC inhibitors: the 5,11-dihydrodibenzo[b,e]azepin-6-ones as privileged structures. |
Menarini Ricerche Pomezia |
22435669 |
16 |
Discovery and extensive in vitro evaluations of NK-HDAC-1: a chiral histone deacetylase inhibitor as a promising lead. |
Nankai University |
22326398 |
22 |
Inhibitors of human histone deacetylase with potent activity against the African trypanosome Trypanosoma brucei. |
London School of Hygiene and Tropical Medicine |
21978679 |
10 |
4-N-Hydroxy-4-[1-(sulfonyl)piperidin-4-yl]-butyramides as HDAC inhibitors. |
Menarini Ricerche Pomezia |
21621883 |
18 |
Structure-based optimization of click-based histone deacetylase inhibitors. |
Nankai University |
21420859 |
7 |
Alkyl piperidine and piperazine hydroxamic acids as HDAC inhibitors. |
Menarini Ricerche Pomezia |
24900225 |
26 |
Antiproliferative and differentiating activities of a novel series of histone deacetylase inhibitors. |
Menarini Ricerche |
19223622 |
8 |
Novel inhibitor of Plasmodium histone deacetylase that cures P. berghei-infected mice. |
Georgetown University Medical Center |
21067930 |
8 |
Discovery of 1H-benzo[d][1,2,3]triazol-1-yl 3,4,5-trimethoxybenzoate as a potential antiproliferative agent by inhibiting histone deacetylase. |
Nanjing University |
16921367 |
19 |
Histone deacetylase inhibitors reverse gene silencing in Friedreich's ataxia. |
The Scripps Research Institute |
20576572 |
15 |
New aryldithiolethione derivatives as potent histone deacetylase inhibitors. |
Sulfidris |
20167479 |
3 |
SelSA, selenium analogs of SAHA as potent histone deacetylase inhibitors. |
Pennsylvania State Hershey College of Medicine |
20036560 |
5 |
Fluoroalkene modification of mercaptoacetamide-based histone deacetylase inhibitors. |
Saga University |
19914074 |
13 |
Antimalarial and antileishmanial activities of histone deacetylase inhibitors with triazole-linked cap group. |
Georgia Institute of Technology |
20017493 |
29 |
Synthesis and biological evaluation of N-hydroxyphenylacrylamides and N-hydroxypyridin-2-ylacrylamides as novel histone deacetylase inhibitors. |
Congenia |
19520580 |
17 |
Molecular modifications on carboxylic acid derivatives as potent histone deacetylase inhibitors: Activity and docking studies. |
Hacettepe University |
19534534 |
3 |
Recent advances in the development of polyamine analogues as antitumor agents. |
Johns Hopkins University |
19344175 |
3 |
Synthesis, biological evaluation, and molecular docking of Ugi products containing a zinc-chelating moiety as novel inhibitors of histone deacetylases. |
Universita Degli Studi Del Piemonte Orientale A. Avogadro |
18954984 |
38 |
Alpha-mercaptoketone based histone deacetylase inhibitors. |
Kalypsys |
18397827 |
29 |
Synthesis and structure-activity relationship of histone deacetylase (HDAC) inhibitors with triazole-linked cap group. |
Georgia Institute of Technology |
18348516 |
2 |
Polyaminohydroxamic acids and polyaminobenzamides as isoform selective histone deacetylase inhibitors. |
Wayne State University |
18294844 |
8 |
New sulfurated derivatives of valproic acid with enhanced histone deacetylase inhibitory activity. |
Sulfidris |
17904843 |
20 |
Modification of cap group in delta-lactam-based histone deacetylase (HDAC) inhibitors. |
Korea Research Institute of Bioscience and Biotechnology |
17827005 |
24 |
Design and synthesis of thiazole-5-hydroxamic acids as novel histone deacetylase inhibitors. |
Entremed |
17662606 |
3 |
Pomiferin, histone deacetylase inhibitor isolated from the fruits of Maclura pomifera. |
Wonkwang University |
17532630 |
4 |
Design, synthesis, and biological activity of folate receptor-targeted prodrugs of thiolate histone deacetylase inhibitors. |
Nagoya City University |
17307359 |
9 |
Structural requirements of HDAC inhibitors: SAHA analogs functionalized adjacent to the hydroxamic acid. |
Wayne State University |
17477518 |
15 |
Structure-activity relationship studies of a series of novel delta-lactam-based histone deacetylase inhibitors. |
Kribb |
16723227 |
5 |
Synthesis, enzymatic inhibition, and cancer cell growth inhibition of novel delta-lactam-based histone deacetylase (HDAC) inhibitors. |
Korea Research Institute of Bioscience and Biotechnology |
16420064 |
35 |
Aromatic sulfide inhibitors of histone deacetylase based on arylsulfinyl-2,4-hexadienoic acid hydroxyamides. |
University College London |
16190761 |
14 |
Alkyl-substituted polyaminohydroxamic acids: a novel class of targeted histone deacetylase inhibitors. |
Wayne State University |
15715470 |
37 |
Novel inhibitors of human histone deacetylases: design, synthesis, enzyme inhibition, and cancer cell growth inhibition of SAHA-based non-hydroxamates. |
Nagoya City University |
16107152 |
16 |
Structure-based optimization of phenylbutyrate-derived histone deacetylase inhibitors. |
The Ohio State University |
15456267 |
26 |
Subtype selective substrates for histone deacetylases. |
Westf£Lische Wilhelms-Universit£T M£Nster |
15808449 |
13 |
Mercaptoamide-based non-hydroxamic acid type histone deacetylase inhibitors. |
Miikana Therapeutics |
15603949 |
10 |
Identification of a potent non-hydroxamate histone deacetylase inhibitor by mechanism-based drug design. |
Nagoya City University |
14711316 |
22 |
Zn2+-chelating motif-tethered short-chain fatty acids as a novel class of histone deacetylase inhibitors. |
The Ohio State University |
14667227 |
8 |
Synthesis and biological evaluation of 3-(4-substituted-phenyl)-N-hydroxy-2-propenamides, a new class of histone deacetylase inhibitors. |
In2Gen |
14521422 |
41 |
N-hydroxy-3-phenyl-2-propenamides as novel inhibitors of human histone deacetylase with in vivo antitumor activity: discovery of (2E)-N-hydroxy-3-[4-[[(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2-propenamide (NVP-LAQ824). |
Novartis Institute For Biomedical Research |
11831887 |
34 |
Inhibitors of human histone deacetylase: synthesis and enzyme and cellular activity of straight chain hydroxamates. |
TBA |
10425110 |
16 |
Synthesis and histone deacetylase inhibitory activity of new benzamide derivatives. |
Mitsui Pharmaceuticals |
29738953 |
34 |
Design and biological evaluation of tetrahydro-?-carboline derivatives as highly potent histone deacetylase 6 (HDAC6) inhibitors. |
University of Regensburg |
28814374 |
19 |
From bench (laboratory) to bed (hospital/home): How to explore effective natural and synthetic PAK1-blockers/longevity-promoters for cancer therapy. |
Pak Research Center |
29541353 |
18 |
Histone Deacetylase Inhibitors as Treatment for Targeting Multiple Components in Cancer Therapy. |
Usona Institute |
29456804 |
5 |
Biocompatible Boron-Containing Prodrugs of Belinostat for the Potential Treatment of Solid Tumors. |
Xavier University of Louisiana |
29202397 |
25 |
Design, synthesis and biological evaluation of novel 2-aminobenzamides containing dithiocarbamate moiety as histone deacetylase inhibitors and potent antitumor agents. |
Beijing University of Chemical Technology |
29150335 |
13 |
Camptothecin-psammaplin A hybrids as topoisomerase I and HDAC dual-action inhibitors. |
Universit£ |
29150330 |
54 |
The structural requirements of histone deacetylase inhibitors: C4-modified SAHA analogs display dual HDAC6/HDAC8 selectivity. |
Wayne State University |
30122227 |
113 |
Squaramides as novel class I and IIB histone deacetylase inhibitors for topical treatment of cutaneous t-cell lymphoma. |
Nestle Skin Health R&D |
29567459 |
49 |
1-Aroylindoline-hydroxamic acids as anticancer agents, inhibitors of HSP90 and HDAC. |
Taipei Medical University |
29500131 |
38 |
Structure optimization and preliminary bioactivity evaluation of N-hydroxybenzamide-based HDAC inhibitors with Y-shaped cap. |
Shandong University |
29500130 |
152 |
Design, synthesis and biological evaluation of novel hydroxamic acid based histone deacetylase 6 selective inhibitors bearing phenylpyrazol scaffold as surface recognition motif. |
Shenyang Pharmaceutical University |
29549837 |
151 |
Design, synthesis, biological evaluation and in vivo testing of dual phosphodiesterase 5 (PDE5) and histone deacetylase 6 (HDAC6)-selective inhibitors for the treatment of Alzheimer's disease. |
University of Navarra |
29505935 |
13 |
Indole in the target-based design of anticancer agents: A versatile scaffold with diverse mechanisms. |
Mazandaran University of Medical Sciences |
29787262 |
64 |
Discovery of Novel Pazopanib-Based HDAC and VEGFR Dual Inhibitors Targeting Cancer Epigenetics and Angiogenesis Simultaneously. |
Shandong University |
29396364 |
16 |
Spirohydantoins and 1,2,4-triazole-3-carboxamide derivatives as inhibitors of histone deacetylase: Design, synthesis, and biological evaluation. |
Minia University |
29348808 |
35 |
Dual NAMPT/HDAC Inhibitors as a New Strategy for Multitargeting Antitumor Drug Discovery. |
Second Military Medical University |
29259737 |
10 |
Novel Polyamine-Naphthalene Diimide Conjugates Targeting Histone Deacetylases and DNA for Cancer Phenotype Reprogramming. |
Alma Mater Studiorum-University of Bologna |
29223096 |
45 |
Discovery of aliphatic-chain hydroxamates containing indole derivatives with potent class I histone deacetylase inhibitory activities. |
Taipei Medical University |
29031066 |
3 |
Serendipitous discovery of potent human head and neck squamous cell carcinoma anti-cancer molecules: A fortunate failure of a rational molecular design. |
Universit£ |
29776742 |
55 |
Discovery of novel N-hydroxy-2-arylisoindoline-4-carboxamides as potent and selective inhibitors of HDAC11. |
Forma Therapeutics |
28368585 |
18 |
Exploring Derivatives of Quinazoline Alkaloid l-Vasicine as Cap Groups in the Design and Biological Mechanistic Evaluation of Novel Antitumor Histone Deacetylase Inhibitors. |
Csir-Indian Institute of Integrative Medicine |
29589441 |
78 |
Marbostat-100 Defines a New Class of Potent and Selective Antiinflammatory and Antirheumatic Histone Deacetylase 6 Inhibitors. |
University of Regensburg |
27886544 |
46 |
3-Aroylindoles display antitumor activity in vitro and in vivo: Effects of N1-substituents on biological activity. |
Taipei Medical University |
28771357 |
50 |
Class I HDAC Inhibitors: Potential New Epigenetic Therapeutics for Alcohol Use Disorder (AUD). |
Universit£ |
28453994 |
118 |
Synthesis and applications of benzohydroxamic acid-based histone deacetylase inhibitors. |
Ghent University |
28549219 |
30 |
Design, Synthesis, and Properties of a Potent Inhibitor of Pseudomonas aeruginosa Deacetylase LpxC. |
Novartis Institutes For Biomedical Research |
29304284 |
59 |
(N-Hydroxycarbonylbenylamino)quinolines as Selective Histone Deacetylase 6 Inhibitors Suppress Growth of Multiple Myeloma in Vitro and in Vivo. |
Taipei Medical University |
29499113 |
77 |
Class I HDAC Inhibitors Display Different Antitumor Mechanism in Leukemia and Prostatic Cancer Cells Depending on Their p53 Status. |
Medical University of South Carolina |
28415009 |
51 |
Selective HDAC inhibitors with potent oral activity against leukemia and colorectal cancer: Design, structure-activity relationship and anti-tumor activity study. |
Shandong University |
28395150 |
30 |
4-Indolyl-N-hydroxyphenylacrylamides as potent HDAC class I and IIB inhibitors in vitro and in vivo. |
Taipei Medical University (Tmu) |
28885834 |
80 |
Small Molecule Inhibitors Simultaneously Targeting Cancer Metabolism and Epigenetics: Discovery of Novel Nicotinamide Phosphoribosyltransferase (NAMPT) and Histone Deacetylase (HDAC) Dual Inhibitors. |
Second Military Medical University |
28581289 |
20 |
Alkoxyurea-Based Histone Deacetylase Inhibitors Increase Cisplatin Potency in Chemoresistant Cancer Cell Lines. |
Heinrich-Heine-Universit£T D£Sseldorf |
27416889 |
35 |
Design, synthesis, and preliminary bioactivity evaluation of N(1) -hydroxyterephthalamide derivatives with indole cap as novel histone deacetylase inhibitors. |
Shandong University |
14500743 |
60 |
Carbamoylcholine homologs: novel and potent agonists at neuronal nicotinic acetylcholine receptors. |
The Danish University of Pharmaceutical Sciences |
12065700 |
14 |
Biochemistry and pharmacology of epitope-tagged alpha(1)-adrenergic receptor subtypes. |
Emory University |
1586393 |
43 |
Localization and function of the D3 dopamine receptor. |
U. 109 |
1554381 |
19 |
Agonist activity of 2- and 5'-substituted adenosine analogs and their N6-cycloalkyl derivatives at A1- and A2-adenosine receptors coupled to adenylate cyclase. |
National Institutes of Diabetes and Digestive and Kidney Diseases |
1501121 |
12 |
Biochemical and pharmacological properties of SR 46349B, a new potent and selective 5-hydroxytryptamine2 receptor antagonist. |
Sanofi Recherche |
282646 |
50 |
Histamine H1 receptors identified in mammalian brain membranes with [3H]mepyramine. |
TBA |
17825569 |
48 |
The influence of modifications in imide fragment structure on 5-HT(1A) and 5-HT(7) receptor affinity and in vivo pharmacological properties of some new 1-(m-trifluoromethylphenyl)piperazines. |
Polish Academy of Sciences |
17218638 |
21 |
Characterization of a potent and selective small-molecule inhibitor of the PIM1 kinase. |
Loma Linda University |
16455247 |
15 |
Pyridone derivatives as potent and selective VLA-4 integrin antagonists. |
Glaxosmithkline |
15566305 |
14 |
Potent N-(1,3-thiazol-2-yl)pyridin-2-amine vascular endothelial growth factor receptor tyrosine kinase inhibitors with excellent pharmacokinetics and low affinity for the hERG ion channel. |
Merck Research Laboratories |
9406595 |
18 |
Design and synthesis of benzoic acid derivatives as influenza neuraminidase inhibitors using structure-based drug design. |
Biocryst Pharmaceuticals |
10530956 |
45 |
Structure-activity relationship of HIV-1 protease inhibitors containing alpha-hydroxy-beta-amino acids. Detailed study of P1 site. |
Sankyo |
25019596 |
24 |
Quinolone-based HDAC inhibitors. |
Orchid Chemicals & Pharmaceuticals |
11472208 |
24 |
Structure-based design, synthesis, and biological evaluation of conformationally restricted novel 2-alkylthio-6-[1-(2,6-difluorophenyl)alkyl]-3,4-dihydro-5-alkylpyrimidin-4(3H)-ones as non-nucleoside inhibitors of HIV-1 reverse transcriptase. |
Sapienza University of Rome |